http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1333025-A4

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44c713790ce00813da2e6c6d57a29456
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
filingDate 2001-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09d411ceee278221de02913dae10f912
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_909420b85823075bb65a7b8289ab9712
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0458971ce127e06e9c1b52d9cb6bab3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5b5e43e70b3e02959291d02929a06a2
publicationDate 2004-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1333025-A4
titleOfInvention CYANOPYRROLIDINE DERIVATIVES
abstract Cyanopyrrolidine derivatives represented by the general formula (1) or pharmaceutically acceptable salts thereof: (1) wherein R1 is halogeno, hydroxyl, or the like, and R2 is hydrogen, halogeno, or the like, or alternatively R?1 and R2¿ are united to form oxo, hydroxyimino, or the like; R?3 and R4¿ are each hydrogen, halogeno, or the like, or alternatively R?3 and R4¿ are united to form oxo, hydroxyimino, or the like; X is oxygen or sulfur; Y is CR5R6- (wherein R?5 and R6¿ are each independently hydrogen, halogeno, or the like) or CR?7R8-CR9R10¿- (wherein R?7, R8, R9, and R10¿ are each independently hydrogen, halogeno, or the like, or alternatively R?7 and R9¿ together with the carbon atoms adjacent thereto form C¿3-8? cycloalkyl or the like); and Z is hydrogen, C1-10 alkyl, or the like, or alternatively Y and Z together with the nitrogen atom adjacent thereto form cyclic C2-10 amino or the like.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8026212-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8198232-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8030270-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8026074-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8017574-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7838254-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8580526-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7833730-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7803754-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8883714-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8486646-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8101626-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8003597-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7803753-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8022034-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7816364-B2
priorityDate 2000-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9819998-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6011155-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0034241-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415751341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457655803

Total number of triples: 59.